These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10558459)

  • 21. International Conference on Harmonisation; guidance on data elements for transmission of individual case safety reports; availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Jan; 63(10):2396-404. PubMed ID: 12296373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA/CVM's Compliance Policy Guide on compounding of drugs.
    J Am Vet Med Assoc; 1996 Dec; 209(12):2025-9. PubMed ID: 8960175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International Conference on Harmonisation; guidance on the duration of chronic toxicity testing in animals (rodent and nonrodent toxicity testing); availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1999 Jun; 64(122):34259-60. PubMed ID: 12356093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current good manufacturing practice regulation and investigational new drugs. Direct final rule.
    Food and Drug Administration. HHS
    Fed Regist; 2006 Jan; 71(10):2458-62. PubMed ID: 16479693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(28):6924-5. PubMed ID: 12583358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agreed minutes; meeting between the Food and Drug Administration and the Health Authorities of Switzerland. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Jun; 64(107):30038-40. PubMed ID: 10558562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(63):16060-1. PubMed ID: 12674113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Nov; 68(220):64628-9. PubMed ID: 14619944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDA issues new security guidance: Operation Liberty Shield.
    Public Health Rep; 2003; 118(3):276. PubMed ID: 12820633
    [No Abstract]   [Full Text] [Related]  

  • 34. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Feb; 73(35):9575-6. PubMed ID: 18677819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of clinical investigations; availability of guideline--FDA. Notice.
    Fed Regist; 1988 Feb; 53(31):4723-4. PubMed ID: 10285639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and maintenance of records under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Dec; 69(236):71561-655. PubMed ID: 15586951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A legal assessment of FDA's new HACCP regulations.
    McNamara SH
    Food Drug Law J; 1997; 52(1):39-47. PubMed ID: 10346708
    [No Abstract]   [Full Text] [Related]  

  • 38. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical device warning letter pilot. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(44):11018-23. PubMed ID: 10557622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(216):56332-3. PubMed ID: 12358038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.